Experimental colitis impairs linear bone growth independent of nutritional factors

Soula Koniaris, Stanley E. Fisher, Clinton T. Rubin, Anupama Chawla

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Background: Poor linear growth frequently complicates chronic inflammatory bowel disease in children. Circulating inflammatory mediators may play a role in this growth delay. We evaluated the effect of experimental colitis on bone growth in a nutritionally controlled rat model. Methods: Experimental colitis was induced in male Sprague-Dawley rats (125-150 g) by enema with trinitrobenzene sulfonic acid in 50% ethanol on day 1 and 11 of a 14-day protocol. Control animals were pair-fed and all animals received a liquid rat diet (1 kcal/ml). Twenty-four-hour urine, collected on days 2 and 12 and serum samples, collected at death, were analyzed for calcium, zinc, and magnesium. Serum samples from a separate set of animals were studied for serial interleukin-6 levels. Right proximal tibias were processed for growth- plate histomorphometry, in which linear growth is proportional to the heights of the proliferative zone, and terminal hypertrophic chondrocyte, but inversely proportional to the height of the resting zone. Results: Histology confirmed active inflammation in the animals given trinitrobenzene sulfonic acid. Weight gain and both urinary excretion and serum levels of zinc, calcium, and magnesium did not differ between treatment and nontreatment groups. Histologically, there was impaired linear bone growth. The resting zone was greater in the colitis group (94.5 ± 32.6 μm versus 3.9 ± 5.4 μm; p < 0.05); the proliferative zone was smaller in the colitis group (123.7 ± 18.2 μm versus 78.9 ± 11.2; p < 0.05 μm); the terminal hypertrophic chondrocyte was reduced in the colitis group (19.5 ± 1.4 μm versus 28.8 ± 3.6 μm; p < 0.05). At 6 and 24 hours after induction, the level of interleukin-6 was elevated in the colitis group. Conclusions: Experimental colitis results in a decreased linear bone growth, independent of nutritional intake. Circulating cytokines derived from intestinal inflammation may contribute to the suppression of bone growth.

Original languageEnglish (US)
Pages (from-to)137-141
Number of pages5
JournalJournal of pediatric gastroenterology and nutrition
Volume25
Issue number2
DOIs
StatePublished - Aug 1 1997

Fingerprint

Bone Development
Colitis
Trinitrobenzenes
Sulfonic Acids
Chondrocytes
Magnesium
Zinc
Interleukin-6
Growth
Serum
Inflammation
Calcium
Growth Plate
Enema
Tibia
Inflammatory Bowel Diseases
Weight Gain
Sprague Dawley Rats
Histology
Ethanol

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health
  • Gastroenterology

Keywords

  • Bone growth
  • Colitis
  • Interleukin-6
  • Rats
  • Trinitrobenzene sulfonic acid

Cite this

Koniaris, Soula ; Fisher, Stanley E. ; Rubin, Clinton T. ; Chawla, Anupama. / Experimental colitis impairs linear bone growth independent of nutritional factors. In: Journal of pediatric gastroenterology and nutrition. 1997 ; Vol. 25, No. 2. pp. 137-141.
@article{a5329daf5fc749988b1ae7478b956e39,
title = "Experimental colitis impairs linear bone growth independent of nutritional factors",
abstract = "Background: Poor linear growth frequently complicates chronic inflammatory bowel disease in children. Circulating inflammatory mediators may play a role in this growth delay. We evaluated the effect of experimental colitis on bone growth in a nutritionally controlled rat model. Methods: Experimental colitis was induced in male Sprague-Dawley rats (125-150 g) by enema with trinitrobenzene sulfonic acid in 50{\%} ethanol on day 1 and 11 of a 14-day protocol. Control animals were pair-fed and all animals received a liquid rat diet (1 kcal/ml). Twenty-four-hour urine, collected on days 2 and 12 and serum samples, collected at death, were analyzed for calcium, zinc, and magnesium. Serum samples from a separate set of animals were studied for serial interleukin-6 levels. Right proximal tibias were processed for growth- plate histomorphometry, in which linear growth is proportional to the heights of the proliferative zone, and terminal hypertrophic chondrocyte, but inversely proportional to the height of the resting zone. Results: Histology confirmed active inflammation in the animals given trinitrobenzene sulfonic acid. Weight gain and both urinary excretion and serum levels of zinc, calcium, and magnesium did not differ between treatment and nontreatment groups. Histologically, there was impaired linear bone growth. The resting zone was greater in the colitis group (94.5 ± 32.6 μm versus 3.9 ± 5.4 μm; p < 0.05); the proliferative zone was smaller in the colitis group (123.7 ± 18.2 μm versus 78.9 ± 11.2; p < 0.05 μm); the terminal hypertrophic chondrocyte was reduced in the colitis group (19.5 ± 1.4 μm versus 28.8 ± 3.6 μm; p < 0.05). At 6 and 24 hours after induction, the level of interleukin-6 was elevated in the colitis group. Conclusions: Experimental colitis results in a decreased linear bone growth, independent of nutritional intake. Circulating cytokines derived from intestinal inflammation may contribute to the suppression of bone growth.",
keywords = "Bone growth, Colitis, Interleukin-6, Rats, Trinitrobenzene sulfonic acid",
author = "Soula Koniaris and Fisher, {Stanley E.} and Rubin, {Clinton T.} and Anupama Chawla",
year = "1997",
month = "8",
day = "1",
doi = "10.1097/00005176-199708000-00002",
language = "English (US)",
volume = "25",
pages = "137--141",
journal = "Journal of Pediatric Gastroenterology and Nutrition",
issn = "0277-2116",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

Experimental colitis impairs linear bone growth independent of nutritional factors. / Koniaris, Soula; Fisher, Stanley E.; Rubin, Clinton T.; Chawla, Anupama.

In: Journal of pediatric gastroenterology and nutrition, Vol. 25, No. 2, 01.08.1997, p. 137-141.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Experimental colitis impairs linear bone growth independent of nutritional factors

AU - Koniaris, Soula

AU - Fisher, Stanley E.

AU - Rubin, Clinton T.

AU - Chawla, Anupama

PY - 1997/8/1

Y1 - 1997/8/1

N2 - Background: Poor linear growth frequently complicates chronic inflammatory bowel disease in children. Circulating inflammatory mediators may play a role in this growth delay. We evaluated the effect of experimental colitis on bone growth in a nutritionally controlled rat model. Methods: Experimental colitis was induced in male Sprague-Dawley rats (125-150 g) by enema with trinitrobenzene sulfonic acid in 50% ethanol on day 1 and 11 of a 14-day protocol. Control animals were pair-fed and all animals received a liquid rat diet (1 kcal/ml). Twenty-four-hour urine, collected on days 2 and 12 and serum samples, collected at death, were analyzed for calcium, zinc, and magnesium. Serum samples from a separate set of animals were studied for serial interleukin-6 levels. Right proximal tibias were processed for growth- plate histomorphometry, in which linear growth is proportional to the heights of the proliferative zone, and terminal hypertrophic chondrocyte, but inversely proportional to the height of the resting zone. Results: Histology confirmed active inflammation in the animals given trinitrobenzene sulfonic acid. Weight gain and both urinary excretion and serum levels of zinc, calcium, and magnesium did not differ between treatment and nontreatment groups. Histologically, there was impaired linear bone growth. The resting zone was greater in the colitis group (94.5 ± 32.6 μm versus 3.9 ± 5.4 μm; p < 0.05); the proliferative zone was smaller in the colitis group (123.7 ± 18.2 μm versus 78.9 ± 11.2; p < 0.05 μm); the terminal hypertrophic chondrocyte was reduced in the colitis group (19.5 ± 1.4 μm versus 28.8 ± 3.6 μm; p < 0.05). At 6 and 24 hours after induction, the level of interleukin-6 was elevated in the colitis group. Conclusions: Experimental colitis results in a decreased linear bone growth, independent of nutritional intake. Circulating cytokines derived from intestinal inflammation may contribute to the suppression of bone growth.

AB - Background: Poor linear growth frequently complicates chronic inflammatory bowel disease in children. Circulating inflammatory mediators may play a role in this growth delay. We evaluated the effect of experimental colitis on bone growth in a nutritionally controlled rat model. Methods: Experimental colitis was induced in male Sprague-Dawley rats (125-150 g) by enema with trinitrobenzene sulfonic acid in 50% ethanol on day 1 and 11 of a 14-day protocol. Control animals were pair-fed and all animals received a liquid rat diet (1 kcal/ml). Twenty-four-hour urine, collected on days 2 and 12 and serum samples, collected at death, were analyzed for calcium, zinc, and magnesium. Serum samples from a separate set of animals were studied for serial interleukin-6 levels. Right proximal tibias were processed for growth- plate histomorphometry, in which linear growth is proportional to the heights of the proliferative zone, and terminal hypertrophic chondrocyte, but inversely proportional to the height of the resting zone. Results: Histology confirmed active inflammation in the animals given trinitrobenzene sulfonic acid. Weight gain and both urinary excretion and serum levels of zinc, calcium, and magnesium did not differ between treatment and nontreatment groups. Histologically, there was impaired linear bone growth. The resting zone was greater in the colitis group (94.5 ± 32.6 μm versus 3.9 ± 5.4 μm; p < 0.05); the proliferative zone was smaller in the colitis group (123.7 ± 18.2 μm versus 78.9 ± 11.2; p < 0.05 μm); the terminal hypertrophic chondrocyte was reduced in the colitis group (19.5 ± 1.4 μm versus 28.8 ± 3.6 μm; p < 0.05). At 6 and 24 hours after induction, the level of interleukin-6 was elevated in the colitis group. Conclusions: Experimental colitis results in a decreased linear bone growth, independent of nutritional intake. Circulating cytokines derived from intestinal inflammation may contribute to the suppression of bone growth.

KW - Bone growth

KW - Colitis

KW - Interleukin-6

KW - Rats

KW - Trinitrobenzene sulfonic acid

UR - http://www.scopus.com/inward/record.url?scp=0030873039&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030873039&partnerID=8YFLogxK

U2 - 10.1097/00005176-199708000-00002

DO - 10.1097/00005176-199708000-00002

M3 - Article

C2 - 9252898

AN - SCOPUS:0030873039

VL - 25

SP - 137

EP - 141

JO - Journal of Pediatric Gastroenterology and Nutrition

JF - Journal of Pediatric Gastroenterology and Nutrition

SN - 0277-2116

IS - 2

ER -